References
Durham AB, Wong SL. Sentinel lymph node biopsy in melanoma: final results of MSLT-I. Future Oncol. 2014;10:1121–3.
Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.
Roaten JB, Pearlman N, Gonzalez R, Gonzalez R, McCarter MD. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma. Arch Surg. 2005;140:85–9.
Banting S, Milne D, Thorpe T, et al. Negative sentinel lymph node biopsy in patients with melanoma: the patient’s perspective. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07375-y.
Belter B, Haase-Kohn C, Pietzsch J. Biomarkers in malignant melanoma: recent trends and critical perspective. In: Ward WH, Farma JM, editors. Cutaneous melanoma: etiology and therapy. Brisbane: Codon Publications; 2017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections offer a brief invited commentary on the article, “Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient’s Perspective”. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07375-y.
Rights and permissions
About this article
Cite this article
Banting, S., Gyorki, D.E. ASO Author Reflections: The Impacts of a Negative Sentinel Lymph Node on Quality of Life. Ann Surg Oncol 26 (Suppl 3), 651–652 (2019). https://doi.org/10.1245/s10434-019-07523-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07523-4